期 |
栏目 |
标题 |
文件 |
卷 78, 编号 11 (2003) |
Editorial |
Results of an open multicenter study of theefficiency of one-week antihelicobacter therapy using omeprazole, clarithromycin, and amoxycillin in patients withduodenal peptic ulcer |
|
卷 86, 编号 2 (2014) |
Editorial |
Patient compliance as one of the factors determining the efficiency of eradication therapy |
|
卷 87, 编号 2 (2015) |
Editorial |
Fecal calprotectin concentration in the differential diagnosis of bowel diseases |
|
卷 88, 编号 2 (2016) |
Editorial |
Specific features of gastroesophageal reflux disease associated with obesity and overweight |
(Rus)
|
卷 88, 编号 2 (2016) |
Editorial |
European Registry on the management of Helicobacter pylori infection (Hp-EuReg protocol): The first results of Russian centers |
(Rus)
|
卷 88, 编号 12 (2016) |
Editorial |
The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease |
(Rus)
|
卷 89, 编号 4 (2017) |
Editorial |
Comparative characteristics of patients with gastroesophageal reflux disease in the age aspect |
(Rus)
|
卷 89, 编号 3 (2017) |
Editorial |
All-Russian Consensus on Diagnosis and Treatment of Celiac Disease in Children and Adults |
(Rus)
|
卷 89, 编号 2 (2017) |
Editorial |
The Russian consensus on the diagnosis and treatment of chronic pancreatitis |
|
卷 89, 编号 8 (2017) |
Editorial |
The Russian consensus on the diagnosis and treatment of chronic pancreatitis: Enzyme replacement therapy |
(Rus)
|
卷 90, 编号 8 (2018) |
Editorial |
Russian consensus on exoand endocrine pancreatic insufficiency after surgical treatment |
(Rus)
|
卷 90, 编号 2 (2018) |
Editorial |
Evropeyskiy registr Helicobacter pylori (Hp-EuReg): analiz dannykh 2360 bol'nykh, poluchavshikh terapiyu pervoy linii v Rossii |
(Rus)
|
卷 91, 编号 2 (2019) |
Editorial |
European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years |
(Rus)
|
卷 91, 编号 8 (2019) |
Editorial |
Underwater rocks of anti - helicobacter therapy |
(Rus)
|